DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Orlowski RZ, Stinchcombe TE, Mitchell BS. et al.
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.
J Clin Oncol 2002; 20: 4420-4427
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.